10-K Filing

ELANCO ANIMAL HEALTH INC CIK: 1739104 FY 2020

Filing Information

Form Type	10-K
Accession Number	`0001739104-21-000004`
Period End Date	20201231
Filing Date	20210301
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	elan-20201231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 80 Income Statement 62 Cash Flow Statement 110 Stockholders Equity 35 Comprehensive Income 20

Balance Sheet 80 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, net of allowances	`AllowanceForDoubtfulAccountsReceivableCurrent`	$8.50M	USD	Point-in-time
Accounts receivable, net of allowances	`AllowanceForDoubtfulAccountsReceivableCurrent`	$6.20M	USD	Point-in-time
Preferred stock authorized (in shares)	`PreferredStockSharesAuthorized`	1.00B	shares	Point-in-time
Preferred stock authorized (in shares)	`PreferredStockSharesAuthorized`	1.00B	shares	Point-in-time
Preferred stock issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$474.80M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$494.70M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$334.00M	USD	Point-in-time
Preferred stock issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net of allowances of $8.5 (2020) and $6.2 (2019)	`AccountsReceivableNetCurrent`	$816.90M	USD	Point-in-time
Common stock authorized (in shares)	`CommonStockSharesAuthorized`	5.00B	shares	Point-in-time
Accounts receivable, net of allowances of $8.5 (2020) and $6.2 (2019)	`AccountsReceivableNetCurrent`	$871.60M	USD	Point-in-time
Common stock authorized (in shares)	`CommonStockSharesAuthorized`	5.00B	shares	Point-in-time
Common stock issued (in shares)	`CommonStockSharesIssued`	471.92M	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$73.00M	USD	Point-in-time
Common stock issued (in shares)	`CommonStockSharesIssued`	373.01M	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$205.10M	USD	Point-in-time
Inventories	`InventoryNet`	$1.05B	USD	Point-in-time
Inventories	`InventoryNet`	$1.58B	USD	Point-in-time
Common stock outstanding (in shares)	`CommonStockSharesOutstanding`	471.92M	shares	Point-in-time
Common stock outstanding (in shares)	`CommonStockSharesOutstanding`	373.01M	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$87.40M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$256.30M	USD	Point-in-time
Restricted cash (Note 21)	`RestrictedCashCurrent`	$202.70M	USD	Point-in-time
Restricted cash (Note 21)	`RestrictedCashCurrent`	$10.70M	USD	Point-in-time
Restricted cash (Note 21)	`RestrictedCashCurrent`	$11.10M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.42B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.37B	USD	Point-in-time
Goodwill	`Goodwill`	$2.99B	USD	Point-in-time
Goodwill	`Goodwill`	$6.22B	USD	Point-in-time
Other intangibles, net	`IntangibleAssetsNetExcludingGoodwill`	$6.39B	USD	Point-in-time
Other intangibles, net	`IntangibleAssetsNetExcludingGoodwill`	$2.48B	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$185.00M	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$347.80M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$955.30M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.32B	USD	Point-in-time
Total assets	`Assets`	$8.99B	USD	Point-in-time
Total assets	`Assets`	$17.69B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$222.60M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$501.00M	USD	Point-in-time
Employee compensation	`EmployeeRelatedLiabilitiesCurrent`	$99.60M	USD	Point-in-time
Employee compensation	`EmployeeRelatedLiabilitiesCurrent`	$143.60M	USD	Point-in-time
Sales rebates and discounts	`ContractWithCustomerLiabilityCurrent`	$295.30M	USD	Point-in-time
Sales rebates and discounts	`ContractWithCustomerLiabilityCurrent`	$211.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$554.50M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$24.50M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$244.40M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$576.90M	USD	Point-in-time
Payable to Lilly (Note 21)	`AccountsPayableRelatedPartiesCurrent`	$16.40M	USD	Point-in-time
Payable to Lilly (Note 21)	`AccountsPayableRelatedPartiesCurrent`	$5.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$818.50M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.08B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$5.57B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$2.33B	USD	Point-in-time
Accrued retirement benefits	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$82.50M	USD	Point-in-time
Accrued retirement benefits	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$345.70M	USD	Point-in-time
Deferred taxes	`DeferredIncomeTaxLiabilitiesNet`	$900.30M	USD	Point-in-time
Deferred taxes	`DeferredIncomeTaxLiabilitiesNet`	$100.80M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$106.60M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$322.10M	USD	Point-in-time
Total liabilities	`Liabilities`	$9.22B	USD	Point-in-time
Total liabilities	`Liabilities`	$3.44B	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, 1,000,000,000 shares authorized, no par value; none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, 1,000,000,000 shares authorized, no par value; none issued	`PreferredStockValue`	-	USD	Point-in-time
Common stock, 5,000,000,000 shares authorized, no par value; 471,921,116 and 373,011,513 shares issued and outstanding as of December 31, 2020 and 2019, respectively	`CommonStockValue`	-	USD	Point-in-time
Common stock, 5,000,000,000 shares authorized, no par value; 471,921,116 and 373,011,513 shares issued and outstanding as of December 31, 2020 and 2019, respectively	`CommonStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$5.64B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$8.65B	USD	Point-in-time
Retained earnings (accumulated deficit)	`RetainedEarningsAccumulatedDeficit`	$-477.20M	USD	Point-in-time
Retained earnings (accumulated deficit)	`RetainedEarningsAccumulatedDeficit`	$84.30M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-173.70M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$303.00M	USD	Point-in-time
Total equity	`StockholdersEquity`	$5.55B	USD	Point-in-time
Total equity	`StockholdersEquity`	$8.48B	USD	Point-in-time
Total equity	`StockholdersEquity`	$7.78B	USD	Point-in-time
Total equity	`StockholdersEquity`	$5.20B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$17.69B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$8.99B	USD	Point-in-time

Income Statement 62 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$787.00M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$3.27B	USD	Annual
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$3.07B	USD	Annual
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.14B	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$3.07B	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$596.20M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$1.47B	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$1.57B	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$1.67B	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$410.10M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$246.60M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$270.10M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$327.00M	USD	Annual
Marketing, selling and administrative	`SellingGeneralAndAdministrativeExpense`	$760.20M	USD	Annual
Marketing, selling and administrative	`SellingGeneralAndAdministrativeExpense`	$996.60M	USD	Annual
Marketing, selling and administrative	`SellingGeneralAndAdministrativeExpense`	$735.20M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$200.40M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$197.40M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$359.90M	USD	Annual
Asset impairment, restructuring and other special charges	`RestructuringSettlementAndImpairmentProvisions`	$128.80M	USD	Annual
Asset impairment, restructuring and other special charges	`RestructuringSettlementAndImpairmentProvisions`	$185.50M	USD	Annual
Asset impairment, restructuring and other special charges	`RestructuringSettlementAndImpairmentProvisions`	$623.70M	USD	Annual
Asset impairment, restructuring and other special charges	`RestructuringSettlementAndImpairmentProvisions`	$51.60M	USD	1 Quarter
Asset impairment, restructuring and other special charges	`RestructuringSettlementAndImpairmentProvisions`	$167.30M	USD	1 Quarter
Interest expense, net of capitalized interest	`InterestExpense`	$149.80M	USD	Annual
Interest expense, net of capitalized interest	`InterestExpense`	$78.90M	USD	Annual
Interest expense, net of capitalized interest	`InterestExpense`	$60.40M	USD	1 Quarter
Interest expense, net of capitalized interest	`InterestExpense`	$29.60M	USD	Annual
Interest expense, net of capitalized interest	`InterestExpense`	$18.70M	USD	1 Quarter
Other expense (income), net	`NonoperatingIncomeExpense`	$-27.40M	USD	Annual
Other expense (income), net	`NonoperatingIncomeExpense`	$178.30M	USD	Annual
Other expense (income), net	`NonoperatingIncomeExpense`	$-41.30M	USD	Annual
Costs, expenses and other	`CostsAndExpenses`	$2.99B	USD	Annual
Costs, expenses and other	`CostsAndExpenses`	$2.95B	USD	Annual
Costs, expenses and other	`CostsAndExpenses`	$3.95B	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$114.10M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-318.10M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-4.30M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-672.00M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$78.20M	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$4.70M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-111.90M	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$27.60M	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$10.30M	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$5.20M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-9.50M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-322.80M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$86.50M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$67.90M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-560.10M	USD	Annual
Basic (usd per share)	`EarningsPerShareBasic`	$-1.27	USD	Annual
Basic (usd per share)	`EarningsPerShareBasic`	$0.18	USD	Annual
Basic (usd per share)	`EarningsPerShareBasic`	$0.28	USD	Annual
Diluted (usd per share)	`EarningsPerShareDiluted`	$-1.27	USD	Annual
Diluted (usd per share)	`EarningsPerShareDiluted`	$0.28	USD	Annual
Diluted (usd per share)	`EarningsPerShareDiluted`	$0.18	USD	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	441.40M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	313.70M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	369.00M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	313.70M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	441.40M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	370.30M	shares	Annual

Cash Flow Statement 110 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-9.50M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-322.80M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$86.50M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$67.90M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-560.10M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$314.50M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$296.00M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$516.90M	USD	Annual
Change in deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-124.80M	USD	Annual
Change in deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-60.70M	USD	Annual
Change in deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$100.00K	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$26.00M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$47.70M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$49.40M	USD	Annual
Asset impairment charges	`AssetImpairmentChargesIncludingInventoryWriteDown`	$120.50M	USD	Annual
Asset impairment charges	`AssetImpairmentChargesIncludingInventoryWriteDown`	$32.60M	USD	Annual
Asset impairment charges	`AssetImpairmentChargesIncludingInventoryWriteDown`	$25.10M	USD	Annual
Gain on sale of assets	`GainLossOnSaleOfOtherAssets`	$800.00K	USD	Annual
Gain on sale of assets	`GainLossOnSaleOfOtherAssets`	-	USD	Annual
Gain on sale of assets	`GainLossOnSaleOfOtherAssets`	$51.30M	USD	Annual
Gain on divestitures	`GainLossOnSaleOfBusiness`	-	USD	Annual
Gain on divestitures	`GainLossOnSaleOfBusiness`	$170.00M	USD	Annual
Gain on divestitures	`GainLossOnSaleOfBusiness`	-	USD	Annual
Inventory fair value step-up amortization	`InventoryFairValueStepUpAmortization`	$90.10M	USD	Annual
Inventory fair value step-up amortization	`InventoryFairValueStepUpAmortization`	$600.00K	USD	Annual
Inventory fair value step-up amortization	`InventoryFairValueStepUpAmortization`	-	USD	Annual
Other non-cash operating activities, net	`OtherOperatingActivitiesCashFlowStatement`	$49.00M	USD	Annual
Other non-cash operating activities, net	`OtherOperatingActivitiesCashFlowStatement`	$19.70M	USD	Annual
Other non-cash operating activities, net	`OtherOperatingActivitiesCashFlowStatement`	$-12.70M	USD	Annual
Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$172.40M	USD	Annual
Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$122.00M	USD	Annual
Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-14.00M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$20.10M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$33.70M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$94.70M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$122.90M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-7.00M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$3.20M	USD	Annual
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$369.30M	USD	Annual
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$-29.20M	USD	Annual
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$116.10M	USD	Annual
Net Cash Provided by (Used for) Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$224.10M	USD	Annual
Net Cash Provided by (Used for) Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$487.30M	USD	Annual
Net Cash Provided by (Used for) Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-41.00M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$134.50M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$134.60M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$140.40M	USD	Annual
Disposals of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$300.00K	USD	Annual
Disposals of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$72.70M	USD	Annual
Disposals of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$9.40M	USD	Annual
Purchases of software	`PaymentsToAcquireSoftware`	$2.00M	USD	Annual
Purchases of software	`PaymentsToAcquireSoftware`	$176.30M	USD	Annual
Purchases of software	`PaymentsToAcquireSoftware`	$57.00M	USD	Annual
Cash paid for acquisitions, net of cash acquired (Note 6)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$32.80M	USD	Annual
Cash paid for acquisitions, net of cash acquired (Note 6)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Cash paid for acquisitions, net of cash acquired (Note 6)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$5.00B	USD	Annual
Divestiture proceeds (Note 6)	`ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates`	-	USD	Annual
Divestiture proceeds (Note 6)	`ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates`	$434.70M	USD	Annual
Divestiture proceeds (Note 6)	`ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates`	-	USD	Annual
Proceeds from settlement of net investment hedges (Note 11)	`ProceedsFromHedgeInvestingActivities`	$32.70M	USD	Annual
Proceeds from settlement of net investment hedges (Note 11)	`ProceedsFromHedgeInvestingActivities`	-	USD	Annual
Proceeds from settlement of net investment hedges (Note 11)	`ProceedsFromHedgeInvestingActivities`	-	USD	Annual
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$7.10M	USD	Annual
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$4.90M	USD	Annual
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-100.00K	USD	Annual
Net Cash Used for Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-234.80M	USD	Annual
Net Cash Used for Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-127.00M	USD	Annual
Net Cash Used for Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-4.78B	USD	Annual
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfSeniorLongTermDebt`	-	USD	Annual
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$2.50B	USD	Annual
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$4.80B	USD	Annual
Repayments of long-term borrowings	`RepaymentsOfSeniorDebt`	$7.50M	USD	Annual
Repayments of long-term borrowings	`RepaymentsOfSeniorDebt`	$121.10M	USD	Annual
Repayments of long-term borrowings	`RepaymentsOfSeniorDebt`	$951.50M	USD	Annual
Proceeds from issuance of common stock and tangible equity units (Note 1 and Note 9)	`ProceedsFromIssuanceOfCommonStock`	$1.22B	USD	Annual
Proceeds from issuance of common stock and tangible equity units (Note 1 and Note 9)	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from issuance of common stock and tangible equity units (Note 1 and Note 9)	`ProceedsFromIssuanceOfCommonStock`	$1.66B	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$102.50M	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$24.50M	USD	Annual
Consideration paid to Lilly in connection with the Separation (Note 1)	`PaymentsOfSeparationRelatedCostsFinancingActivities`	$191.60M	USD	Annual
Consideration paid to Lilly in connection with the Separation (Note 1)	`PaymentsOfSeparationRelatedCostsFinancingActivities`	$3.99B	USD	Annual
Consideration paid to Lilly in connection with the Separation (Note 1)	`PaymentsOfSeparationRelatedCostsFinancingActivities`	-	USD	Annual
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-16.20M	USD	Annual
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-17.20M	USD	Annual
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$1.60M	USD	Annual
Other net transactions with Lilly	`ProceedsFromPaymentsToTransactionsWithParent`	-	USD	Annual
Other net transactions with Lilly	`ProceedsFromPaymentsToTransactionsWithParent`	$6.30M	USD	Annual
Other net transactions with Lilly	`ProceedsFromPaymentsToTransactionsWithParent`	$-154.40M	USD	Annual
Net Cash Provided by (Used for) Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$4.95B	USD	Annual
Net Cash Provided by (Used for) Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$-304.80M	USD	Annual
Net Cash Provided by (Used for) Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$-35.20M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$26.60M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$29.00M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-16.90M	USD	Annual
Net (decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$354.10M	USD	Annual
Net (decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-332.40M	USD	Annual
Net (decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$160.30M	USD	Annual
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$323.40M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$505.40M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$677.50M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$345.10M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$323.40M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$505.40M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$677.50M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$345.10M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$323.40M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$505.40M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$677.50M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$345.10M	USD	Point-in-time

Stockholders Equity 35 line items

Line Item	Tag	Value	Unit	Period
Balance at beginning of period	`StockholdersEquity`	$5.55B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$8.48B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$7.78B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$5.20B	USD	Point-in-time
Net income (loss)	`NetIncomeLoss`	$-9.50M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-322.80M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$86.50M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$67.90M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-560.10M	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$48.50M	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-21.70M	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$476.70M	USD	Annual
Transfers (to)/from Lilly, net	`StockholdersEquityTransfersToFromParent`	$-226.30M	USD	Annual
Separation adjustments	`StockholdersEquitySeparationAdjustments`	$-51.20M	USD	Annual
Separation adjustments	`StockholdersEquitySeparationAdjustments`	$99.60M	USD	Point-in-time
Separation adjustments	`StockholdersEquitySeparationAdjustments`	$99.60M	USD	Annual
Separation adjustments	`StockholdersEquitySeparationAdjustments`	$38.00M	USD	Annual
Issuance of common stock	`StockIssuedDuringPeriodValueNewIssues`	$1.66B	USD	Annual
Consideration to Lilly in connection with Separation	`StockholdersEquityConsiderationToParentInSeparation`	$-4.19B	USD	Annual
Reclassification of net parent company investment	`ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent`	-	USD	Annual
Stock compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$40.70M	USD	Annual
Stock compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$47.70M	USD	Annual
Stock compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.80M	USD	Annual
Issuance of stock under employee stock plans, net	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$14.40M	USD	Annual
Issuance of common stock and tangible equity units, net of issuance costs	`TangibleEquityUnitsIssuedDuringPeriodValue`	$1.22B	USD	Annual
Capital contribution from Lilly	`StockholdersEquityCapitalContributionFromParent`	$12.80M	USD	Annual
Issuance of shares for acquisition	`StockIssuedDuringPeriodValueAcquisitions`	$238.00M	USD	Annual
Issuance of shares for acquisition	`StockIssuedDuringPeriodValueAcquisitions`	$1.72B	USD	Annual
Accelerated vesting of equity awards	`APICShareBasedPaymentArrangementIncreaseForCostRecognitionAcceleratedVesting`	$3.60M	USD	Annual
Other	`StockholdersEquityOther`	$-1.90M	USD	Annual
Other	`StockholdersEquityOther`	$300.00K	USD	Annual
Balance at end of period	`StockholdersEquity`	$5.55B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$8.48B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$7.78B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$5.20B	USD	Point-in-time

Comprehensive Income 20 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-9.50M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-322.80M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$86.50M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$67.90M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-560.10M	USD	Annual
Unrealized loss on derivatives for cash flow hedges, net of taxes	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax`	-	USD	Annual
Unrealized loss on derivatives for cash flow hedges, net of taxes	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax`	$-60.40M	USD	Annual
Unrealized loss on derivatives for cash flow hedges, net of taxes	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax`	-	USD	Annual
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$19.80M	USD	Annual
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-47.10M	USD	Annual
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$558.20M	USD	Annual
Defined benefit pension and retiree health benefit plans, net of taxes	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-28.70M	USD	Annual
Defined benefit pension and retiree health benefit plans, net of taxes	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-25.40M	USD	Annual
Defined benefit pension and retiree health benefit plans, net of taxes	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$21.10M	USD	Annual
Other comprehensive income (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTax`	$48.50M	USD	Annual
Other comprehensive income (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTax`	$-21.70M	USD	Annual
Other comprehensive income (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTax`	$476.70M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$116.40M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-83.40M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$64.80M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.